nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—systemic scleroderma	0.86	1	CiPCiCtD
Decitabine—DNMT3A—connective tissue—systemic scleroderma	0.00263	0.14	CbGeAlD
Decitabine—DNMT3A—skin of body—systemic scleroderma	0.00237	0.127	CbGeAlD
Decitabine—DNMT3A—digestive system—systemic scleroderma	0.0019	0.101	CbGeAlD
Decitabine—DNMT3A—tendon—systemic scleroderma	0.00181	0.0965	CbGeAlD
Decitabine—DNMT1—connective tissue—systemic scleroderma	0.00159	0.0849	CbGeAlD
Decitabine—DNMT3A—lung—systemic scleroderma	0.00159	0.0846	CbGeAlD
Decitabine—DNMT1—skin of body—systemic scleroderma	0.00144	0.0766	CbGeAlD
Decitabine—DNMT1—digestive system—systemic scleroderma	0.00115	0.0613	CbGeAlD
Decitabine—DNMT1—tendon—systemic scleroderma	0.00109	0.0583	CbGeAlD
Decitabine—DNMT1—lung—systemic scleroderma	0.000959	0.0512	CbGeAlD
Decitabine—DCK—digestive system—systemic scleroderma	0.000795	0.0424	CbGeAlD
Decitabine—DCK—tendon—systemic scleroderma	0.000756	0.0404	CbGeAlD
Decitabine—DCK—lung—systemic scleroderma	0.000664	0.0354	CbGeAlD
Decitabine—DNMT3A—Amcinonide—Mometasone—systemic scleroderma	0.000642	0.218	CbGdCrCtD
Decitabine—DNMT3A—Amcinonide—Prednisone—systemic scleroderma	0.00035	0.119	CbGdCrCtD
Decitabine—DNMT1—Budesonide—Mometasone—systemic scleroderma	0.000254	0.0862	CbGdCrCtD
Decitabine—DNMT3A—Betamethasone—Mometasone—systemic scleroderma	0.000205	0.0696	CbGdCrCtD
Decitabine—DNMT3A—Dexamethasone—Mometasone—systemic scleroderma	0.000205	0.0696	CbGdCrCtD
Decitabine—DNMT1—Betamethasone—Mometasone—systemic scleroderma	0.000155	0.0527	CbGdCrCtD
Decitabine—DNMT1—Dexamethasone—Mometasone—systemic scleroderma	0.000155	0.0527	CbGdCrCtD
Decitabine—DCK—Desoximetasone—Mometasone—systemic scleroderma	0.000147	0.0498	CbGdCrCtD
Decitabine—DCK—Diflorasone—Mometasone—systemic scleroderma	0.000142	0.0484	CbGdCrCtD
Decitabine—DNMT1—Budesonide—Prednisone—systemic scleroderma	0.000138	0.047	CbGdCrCtD
Decitabine—DNMT3A—Dexamethasone—Prednisone—systemic scleroderma	0.000112	0.0379	CbGdCrCtD
Decitabine—DNMT3A—Betamethasone—Prednisone—systemic scleroderma	0.000112	0.0379	CbGdCrCtD
Decitabine—DNMT1—Betamethasone—Prednisone—systemic scleroderma	8.45e-05	0.0287	CbGdCrCtD
Decitabine—DNMT1—Dexamethasone—Prednisone—systemic scleroderma	8.45e-05	0.0287	CbGdCrCtD
Decitabine—Dyspnoea—Mycophenolic acid—systemic scleroderma	8.2e-05	0.000691	CcSEcCtD
Decitabine—Thrombocytopenia—Lisinopril—systemic scleroderma	8.11e-05	0.000683	CcSEcCtD
Decitabine—Dyspepsia—Mycophenolic acid—systemic scleroderma	8.09e-05	0.000682	CcSEcCtD
Decitabine—Neutropenia—Prednisone—systemic scleroderma	8.09e-05	0.000681	CcSEcCtD
Decitabine—Tachycardia—Lisinopril—systemic scleroderma	8.08e-05	0.000681	CcSEcCtD
Decitabine—Abdominal pain—Azathioprine—systemic scleroderma	8.07e-05	0.00068	CcSEcCtD
Decitabine—Body temperature increased—Azathioprine—systemic scleroderma	8.07e-05	0.00068	CcSEcCtD
Decitabine—Skin disorder—Lisinopril—systemic scleroderma	8.04e-05	0.000678	CcSEcCtD
Decitabine—Malaise—Mycophenolate mofetil—systemic scleroderma	8.02e-05	0.000676	CcSEcCtD
Decitabine—Diarrhoea—Captopril—systemic scleroderma	8e-05	0.000674	CcSEcCtD
Decitabine—Decreased appetite—Mycophenolic acid—systemic scleroderma	7.99e-05	0.000673	CcSEcCtD
Decitabine—DCK—Desoximetasone—Prednisone—systemic scleroderma	7.99e-05	0.0272	CbGdCrCtD
Decitabine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	7.96e-05	0.000671	CcSEcCtD
Decitabine—Feeling abnormal—Leflunomide—systemic scleroderma	7.94e-05	0.000669	CcSEcCtD
Decitabine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	7.94e-05	0.000669	CcSEcCtD
Decitabine—Fatigue—Mycophenolic acid—systemic scleroderma	7.93e-05	0.000668	CcSEcCtD
Decitabine—Nausea—Mometasone—systemic scleroderma	7.91e-05	0.000666	CcSEcCtD
Decitabine—Anorexia—Lisinopril—systemic scleroderma	7.89e-05	0.000665	CcSEcCtD
Decitabine—Gastrointestinal pain—Leflunomide—systemic scleroderma	7.88e-05	0.000664	CcSEcCtD
Decitabine—Pain—Mycophenolic acid—systemic scleroderma	7.86e-05	0.000662	CcSEcCtD
Decitabine—Constipation—Mycophenolic acid—systemic scleroderma	7.86e-05	0.000662	CcSEcCtD
Decitabine—Weight decreased—Prednisone—systemic scleroderma	7.82e-05	0.000659	CcSEcCtD
Decitabine—Hyperglycaemia—Prednisone—systemic scleroderma	7.8e-05	0.000657	CcSEcCtD
Decitabine—Cough—Mycophenolate mofetil—systemic scleroderma	7.76e-05	0.000654	CcSEcCtD
Decitabine—DCK—Diflorasone—Prednisone—systemic scleroderma	7.75e-05	0.0264	CbGdCrCtD
Decitabine—Hypotension—Lisinopril—systemic scleroderma	7.74e-05	0.000652	CcSEcCtD
Decitabine—Dizziness—Captopril—systemic scleroderma	7.73e-05	0.000652	CcSEcCtD
Decitabine—Liver function test abnormal—Methotrexate—systemic scleroderma	7.72e-05	0.000651	CcSEcCtD
Decitabine—Depression—Prednisone—systemic scleroderma	7.69e-05	0.000648	CcSEcCtD
Decitabine—Hypertension—Mycophenolate mofetil—systemic scleroderma	7.67e-05	0.000647	CcSEcCtD
Decitabine—Urticaria—Leflunomide—systemic scleroderma	7.66e-05	0.000645	CcSEcCtD
Decitabine—Body temperature increased—Leflunomide—systemic scleroderma	7.62e-05	0.000642	CcSEcCtD
Decitabine—Abdominal pain—Leflunomide—systemic scleroderma	7.62e-05	0.000642	CcSEcCtD
Decitabine—Acute coronary syndrome—Prednisone—systemic scleroderma	7.6e-05	0.000641	CcSEcCtD
Decitabine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	7.58e-05	0.000638	CcSEcCtD
Decitabine—Myalgia—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.000638	CcSEcCtD
Decitabine—Chest pain—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.000638	CcSEcCtD
Decitabine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	7.57e-05	0.000638	CcSEcCtD
Decitabine—Myocardial infarction—Prednisone—systemic scleroderma	7.56e-05	0.000637	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	7.54e-05	0.000636	CcSEcCtD
Decitabine—Anxiety—Mycophenolate mofetil—systemic scleroderma	7.54e-05	0.000636	CcSEcCtD
Decitabine—Hypersensitivity—Azathioprine—systemic scleroderma	7.52e-05	0.000634	CcSEcCtD
Decitabine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	7.52e-05	0.000633	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	7.52e-05	0.000633	CcSEcCtD
Decitabine—Insomnia—Lisinopril—systemic scleroderma	7.49e-05	0.000631	CcSEcCtD
Decitabine—Discomfort—Mycophenolate mofetil—systemic scleroderma	7.48e-05	0.00063	CcSEcCtD
Decitabine—Vomiting—Captopril—systemic scleroderma	7.43e-05	0.000626	CcSEcCtD
Decitabine—Dyspnoea—Lisinopril—systemic scleroderma	7.38e-05	0.000622	CcSEcCtD
Decitabine—Rash—Captopril—systemic scleroderma	7.37e-05	0.000621	CcSEcCtD
Decitabine—Dermatitis—Captopril—systemic scleroderma	7.37e-05	0.000621	CcSEcCtD
Decitabine—Headache—Captopril—systemic scleroderma	7.32e-05	0.000617	CcSEcCtD
Decitabine—Confusional state—Mycophenolate mofetil—systemic scleroderma	7.32e-05	0.000616	CcSEcCtD
Decitabine—Dyspepsia—Lisinopril—systemic scleroderma	7.29e-05	0.000614	CcSEcCtD
Decitabine—Abdominal pain—Mycophenolic acid—systemic scleroderma	7.27e-05	0.000612	CcSEcCtD
Decitabine—Body temperature increased—Mycophenolic acid—systemic scleroderma	7.27e-05	0.000612	CcSEcCtD
Decitabine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	7.26e-05	0.000611	CcSEcCtD
Decitabine—Oedema—Mycophenolate mofetil—systemic scleroderma	7.26e-05	0.000611	CcSEcCtD
Decitabine—Infection—Mycophenolate mofetil—systemic scleroderma	7.21e-05	0.000607	CcSEcCtD
Decitabine—Decreased appetite—Lisinopril—systemic scleroderma	7.2e-05	0.000607	CcSEcCtD
Decitabine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	7.15e-05	0.000602	CcSEcCtD
Decitabine—Fatigue—Lisinopril—systemic scleroderma	7.14e-05	0.000602	CcSEcCtD
Decitabine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	7.11e-05	0.0006	CcSEcCtD
Decitabine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	7.1e-05	0.000599	CcSEcCtD
Decitabine—Hypersensitivity—Leflunomide—systemic scleroderma	7.1e-05	0.000598	CcSEcCtD
Decitabine—Constipation—Lisinopril—systemic scleroderma	7.08e-05	0.000597	CcSEcCtD
Decitabine—Pain—Lisinopril—systemic scleroderma	7.08e-05	0.000597	CcSEcCtD
Decitabine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	7.08e-05	0.000597	CcSEcCtD
Decitabine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	7.05e-05	0.000594	CcSEcCtD
Decitabine—Diarrhoea—Azathioprine—systemic scleroderma	6.98e-05	0.000588	CcSEcCtD
Decitabine—Haemoglobin—Prednisone—systemic scleroderma	6.96e-05	0.000586	CcSEcCtD
Decitabine—Nausea—Captopril—systemic scleroderma	6.95e-05	0.000585	CcSEcCtD
Decitabine—Haemorrhage—Prednisone—systemic scleroderma	6.92e-05	0.000583	CcSEcCtD
Decitabine—Anorexia—Mycophenolate mofetil—systemic scleroderma	6.92e-05	0.000583	CcSEcCtD
Decitabine—Asthenia—Leflunomide—systemic scleroderma	6.91e-05	0.000583	CcSEcCtD
Decitabine—Pancytopenia—Methotrexate—systemic scleroderma	6.86e-05	0.000578	CcSEcCtD
Decitabine—Feeling abnormal—Lisinopril—systemic scleroderma	6.82e-05	0.000575	CcSEcCtD
Decitabine—Pruritus—Leflunomide—systemic scleroderma	6.82e-05	0.000575	CcSEcCtD
Decitabine—Connective tissue disorder—Prednisone—systemic scleroderma	6.8e-05	0.000573	CcSEcCtD
Decitabine—Hypotension—Mycophenolate mofetil—systemic scleroderma	6.78e-05	0.000571	CcSEcCtD
Decitabine—Gastrointestinal pain—Lisinopril—systemic scleroderma	6.77e-05	0.000571	CcSEcCtD
Decitabine—Dysuria—Methotrexate—systemic scleroderma	6.76e-05	0.000569	CcSEcCtD
Decitabine—Neutropenia—Methotrexate—systemic scleroderma	6.76e-05	0.000569	CcSEcCtD
Decitabine—Dizziness—Azathioprine—systemic scleroderma	6.75e-05	0.000569	CcSEcCtD
Decitabine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	6.72e-05	0.000566	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	6.61e-05	0.000557	CcSEcCtD
Decitabine—Asthenia—Mycophenolic acid—systemic scleroderma	6.6e-05	0.000556	CcSEcCtD
Decitabine—Diarrhoea—Leflunomide—systemic scleroderma	6.59e-05	0.000556	CcSEcCtD
Decitabine—Urticaria—Lisinopril—systemic scleroderma	6.58e-05	0.000554	CcSEcCtD
Decitabine—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.56e-05	0.000553	CcSEcCtD
Decitabine—Abdominal pain—Lisinopril—systemic scleroderma	6.55e-05	0.000552	CcSEcCtD
Decitabine—Body temperature increased—Lisinopril—systemic scleroderma	6.55e-05	0.000552	CcSEcCtD
Decitabine—Pruritus—Mycophenolic acid—systemic scleroderma	6.5e-05	0.000548	CcSEcCtD
Decitabine—Vomiting—Azathioprine—systemic scleroderma	6.49e-05	0.000547	CcSEcCtD
Decitabine—Pneumonia—Methotrexate—systemic scleroderma	6.48e-05	0.000546	CcSEcCtD
Decitabine—Eye disorder—Prednisone—systemic scleroderma	6.47e-05	0.000545	CcSEcCtD
Decitabine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.47e-05	0.000545	CcSEcCtD
Decitabine—Infestation NOS—Methotrexate—systemic scleroderma	6.44e-05	0.000543	CcSEcCtD
Decitabine—Infestation—Methotrexate—systemic scleroderma	6.44e-05	0.000543	CcSEcCtD
Decitabine—Rash—Azathioprine—systemic scleroderma	6.43e-05	0.000542	CcSEcCtD
Decitabine—Dermatitis—Azathioprine—systemic scleroderma	6.43e-05	0.000542	CcSEcCtD
Decitabine—Depression—Methotrexate—systemic scleroderma	6.43e-05	0.000541	CcSEcCtD
Decitabine—Headache—Azathioprine—systemic scleroderma	6.39e-05	0.000539	CcSEcCtD
Decitabine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	6.39e-05	0.000538	CcSEcCtD
Decitabine—Dizziness—Leflunomide—systemic scleroderma	6.37e-05	0.000537	CcSEcCtD
Decitabine—Renal failure—Methotrexate—systemic scleroderma	6.33e-05	0.000534	CcSEcCtD
Decitabine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	6.31e-05	0.000531	CcSEcCtD
Decitabine—Diarrhoea—Mycophenolic acid—systemic scleroderma	6.29e-05	0.00053	CcSEcCtD
Decitabine—Stomatitis—Methotrexate—systemic scleroderma	6.28e-05	0.000529	CcSEcCtD
Decitabine—Angiopathy—Prednisone—systemic scleroderma	6.28e-05	0.000529	CcSEcCtD
Decitabine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	6.26e-05	0.000528	CcSEcCtD
Decitabine—Immune system disorder—Prednisone—systemic scleroderma	6.25e-05	0.000527	CcSEcCtD
Decitabine—Pain—Mycophenolate mofetil—systemic scleroderma	6.2e-05	0.000523	CcSEcCtD
Decitabine—Constipation—Mycophenolate mofetil—systemic scleroderma	6.2e-05	0.000523	CcSEcCtD
Decitabine—Vomiting—Leflunomide—systemic scleroderma	6.13e-05	0.000516	CcSEcCtD
Decitabine—Alopecia—Prednisone—systemic scleroderma	6.12e-05	0.000515	CcSEcCtD
Decitabine—Hypersensitivity—Lisinopril—systemic scleroderma	6.1e-05	0.000514	CcSEcCtD
Decitabine—Hepatobiliary disease—Methotrexate—systemic scleroderma	6.09e-05	0.000514	CcSEcCtD
Decitabine—Dizziness—Mycophenolic acid—systemic scleroderma	6.08e-05	0.000512	CcSEcCtD
Decitabine—Epistaxis—Methotrexate—systemic scleroderma	6.08e-05	0.000512	CcSEcCtD
Decitabine—Rash—Leflunomide—systemic scleroderma	6.08e-05	0.000512	CcSEcCtD
Decitabine—Dermatitis—Leflunomide—systemic scleroderma	6.07e-05	0.000512	CcSEcCtD
Decitabine—Mental disorder—Prednisone—systemic scleroderma	6.06e-05	0.000511	CcSEcCtD
Decitabine—Nausea—Azathioprine—systemic scleroderma	6.06e-05	0.000511	CcSEcCtD
Decitabine—Headache—Leflunomide—systemic scleroderma	6.04e-05	0.000509	CcSEcCtD
Decitabine—Malnutrition—Prednisone—systemic scleroderma	6.03e-05	0.000508	CcSEcCtD
Decitabine—Erythema—Prednisone—systemic scleroderma	6.03e-05	0.000508	CcSEcCtD
Decitabine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	5.98e-05	0.000504	CcSEcCtD
Decitabine—Asthenia—Lisinopril—systemic scleroderma	5.94e-05	0.000501	CcSEcCtD
Decitabine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	5.93e-05	0.0005	CcSEcCtD
Decitabine—Pruritus—Lisinopril—systemic scleroderma	5.86e-05	0.000494	CcSEcCtD
Decitabine—Vomiting—Mycophenolic acid—systemic scleroderma	5.85e-05	0.000493	CcSEcCtD
Decitabine—Haemoglobin—Methotrexate—systemic scleroderma	5.81e-05	0.00049	CcSEcCtD
Decitabine—Rash—Mycophenolic acid—systemic scleroderma	5.8e-05	0.000488	CcSEcCtD
Decitabine—Dermatitis—Mycophenolic acid—systemic scleroderma	5.79e-05	0.000488	CcSEcCtD
Decitabine—Haemorrhage—Methotrexate—systemic scleroderma	5.79e-05	0.000487	CcSEcCtD
Decitabine—Urticaria—Mycophenolate mofetil—systemic scleroderma	5.76e-05	0.000486	CcSEcCtD
Decitabine—Headache—Mycophenolic acid—systemic scleroderma	5.76e-05	0.000485	CcSEcCtD
Decitabine—Pharyngitis—Methotrexate—systemic scleroderma	5.74e-05	0.000484	CcSEcCtD
Decitabine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	5.74e-05	0.000483	CcSEcCtD
Decitabine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	5.74e-05	0.000483	CcSEcCtD
Decitabine—Nausea—Leflunomide—systemic scleroderma	5.72e-05	0.000482	CcSEcCtD
Decitabine—Urinary tract disorder—Methotrexate—systemic scleroderma	5.71e-05	0.000481	CcSEcCtD
Decitabine—Vision blurred—Prednisone—systemic scleroderma	5.68e-05	0.000479	CcSEcCtD
Decitabine—Urethral disorder—Methotrexate—systemic scleroderma	5.67e-05	0.000478	CcSEcCtD
Decitabine—Diarrhoea—Lisinopril—systemic scleroderma	5.67e-05	0.000477	CcSEcCtD
Decitabine—Ill-defined disorder—Prednisone—systemic scleroderma	5.59e-05	0.000471	CcSEcCtD
Decitabine—Anaemia—Prednisone—systemic scleroderma	5.57e-05	0.000469	CcSEcCtD
Decitabine—Dizziness—Lisinopril—systemic scleroderma	5.48e-05	0.000461	CcSEcCtD
Decitabine—Nausea—Mycophenolic acid—systemic scleroderma	5.46e-05	0.00046	CcSEcCtD
Decitabine—Malaise—Prednisone—systemic scleroderma	5.43e-05	0.000458	CcSEcCtD
Decitabine—Eye disorder—Methotrexate—systemic scleroderma	5.41e-05	0.000456	CcSEcCtD
Decitabine—Cardiac disorder—Methotrexate—systemic scleroderma	5.37e-05	0.000452	CcSEcCtD
Decitabine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.35e-05	0.00045	CcSEcCtD
Decitabine—Vomiting—Lisinopril—systemic scleroderma	5.26e-05	0.000444	CcSEcCtD
Decitabine—Angiopathy—Methotrexate—systemic scleroderma	5.25e-05	0.000442	CcSEcCtD
Decitabine—Immune system disorder—Methotrexate—systemic scleroderma	5.23e-05	0.00044	CcSEcCtD
Decitabine—Rash—Lisinopril—systemic scleroderma	5.22e-05	0.00044	CcSEcCtD
Decitabine—Dermatitis—Lisinopril—systemic scleroderma	5.22e-05	0.00044	CcSEcCtD
Decitabine—Mediastinal disorder—Methotrexate—systemic scleroderma	5.21e-05	0.000439	CcSEcCtD
Decitabine—Asthenia—Mycophenolate mofetil—systemic scleroderma	5.21e-05	0.000439	CcSEcCtD
Decitabine—Hypertension—Prednisone—systemic scleroderma	5.2e-05	0.000438	CcSEcCtD
Decitabine—Chills—Methotrexate—systemic scleroderma	5.19e-05	0.000437	CcSEcCtD
Decitabine—Headache—Lisinopril—systemic scleroderma	5.19e-05	0.000437	CcSEcCtD
Decitabine—Pruritus—Mycophenolate mofetil—systemic scleroderma	5.13e-05	0.000433	CcSEcCtD
Decitabine—Arthralgia—Prednisone—systemic scleroderma	5.13e-05	0.000432	CcSEcCtD
Decitabine—Myalgia—Prednisone—systemic scleroderma	5.13e-05	0.000432	CcSEcCtD
Decitabine—Anxiety—Prednisone—systemic scleroderma	5.11e-05	0.000431	CcSEcCtD
Decitabine—Alopecia—Methotrexate—systemic scleroderma	5.11e-05	0.000431	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	5.09e-05	0.000429	CcSEcCtD
Decitabine—Discomfort—Prednisone—systemic scleroderma	5.07e-05	0.000427	CcSEcCtD
Decitabine—Mental disorder—Methotrexate—systemic scleroderma	5.07e-05	0.000427	CcSEcCtD
Decitabine—Malnutrition—Methotrexate—systemic scleroderma	5.04e-05	0.000424	CcSEcCtD
Decitabine—Erythema—Methotrexate—systemic scleroderma	5.04e-05	0.000424	CcSEcCtD
Decitabine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	4.96e-05	0.000418	CcSEcCtD
Decitabine—Nausea—Lisinopril—systemic scleroderma	4.92e-05	0.000414	CcSEcCtD
Decitabine—Oedema—Prednisone—systemic scleroderma	4.92e-05	0.000414	CcSEcCtD
Decitabine—Anaphylactic shock—Prednisone—systemic scleroderma	4.92e-05	0.000414	CcSEcCtD
Decitabine—Infection—Prednisone—systemic scleroderma	4.89e-05	0.000412	CcSEcCtD
Decitabine—Back pain—Methotrexate—systemic scleroderma	4.87e-05	0.00041	CcSEcCtD
Decitabine—Nervous system disorder—Prednisone—systemic scleroderma	4.82e-05	0.000406	CcSEcCtD
Decitabine—Tachycardia—Prednisone—systemic scleroderma	4.8e-05	0.000404	CcSEcCtD
Decitabine—Dizziness—Mycophenolate mofetil—systemic scleroderma	4.8e-05	0.000404	CcSEcCtD
Decitabine—Skin disorder—Prednisone—systemic scleroderma	4.78e-05	0.000403	CcSEcCtD
Decitabine—Vision blurred—Methotrexate—systemic scleroderma	4.75e-05	0.0004	CcSEcCtD
Decitabine—Anorexia—Prednisone—systemic scleroderma	4.69e-05	0.000395	CcSEcCtD
Decitabine—Ill-defined disorder—Methotrexate—systemic scleroderma	4.67e-05	0.000394	CcSEcCtD
Decitabine—Anaemia—Methotrexate—systemic scleroderma	4.65e-05	0.000392	CcSEcCtD
Decitabine—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.61e-05	0.000389	CcSEcCtD
Decitabine—Rash—Mycophenolate mofetil—systemic scleroderma	4.57e-05	0.000385	CcSEcCtD
Decitabine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.57e-05	0.000385	CcSEcCtD
Decitabine—Headache—Mycophenolate mofetil—systemic scleroderma	4.55e-05	0.000383	CcSEcCtD
Decitabine—Malaise—Methotrexate—systemic scleroderma	4.54e-05	0.000383	CcSEcCtD
Decitabine—Leukopenia—Methotrexate—systemic scleroderma	4.51e-05	0.00038	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.48e-05	0.000378	CcSEcCtD
Decitabine—Insomnia—Prednisone—systemic scleroderma	4.45e-05	0.000375	CcSEcCtD
Decitabine—Cough—Methotrexate—systemic scleroderma	4.39e-05	0.00037	CcSEcCtD
Decitabine—Dyspepsia—Prednisone—systemic scleroderma	4.33e-05	0.000365	CcSEcCtD
Decitabine—Nausea—Mycophenolate mofetil—systemic scleroderma	4.31e-05	0.000363	CcSEcCtD
Decitabine—Arthralgia—Methotrexate—systemic scleroderma	4.29e-05	0.000361	CcSEcCtD
Decitabine—Myalgia—Methotrexate—systemic scleroderma	4.29e-05	0.000361	CcSEcCtD
Decitabine—Chest pain—Methotrexate—systemic scleroderma	4.29e-05	0.000361	CcSEcCtD
Decitabine—Decreased appetite—Prednisone—systemic scleroderma	4.28e-05	0.00036	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	4.26e-05	0.000359	CcSEcCtD
Decitabine—Fatigue—Prednisone—systemic scleroderma	4.24e-05	0.000357	CcSEcCtD
Decitabine—Discomfort—Methotrexate—systemic scleroderma	4.24e-05	0.000357	CcSEcCtD
Decitabine—Constipation—Prednisone—systemic scleroderma	4.21e-05	0.000354	CcSEcCtD
Decitabine—Confusional state—Methotrexate—systemic scleroderma	4.14e-05	0.000349	CcSEcCtD
Decitabine—Anaphylactic shock—Methotrexate—systemic scleroderma	4.11e-05	0.000346	CcSEcCtD
Decitabine—Infection—Methotrexate—systemic scleroderma	4.08e-05	0.000344	CcSEcCtD
Decitabine—Feeling abnormal—Prednisone—systemic scleroderma	4.05e-05	0.000341	CcSEcCtD
Decitabine—Nervous system disorder—Methotrexate—systemic scleroderma	4.03e-05	0.00034	CcSEcCtD
Decitabine—Thrombocytopenia—Methotrexate—systemic scleroderma	4.02e-05	0.000339	CcSEcCtD
Decitabine—Gastrointestinal pain—Prednisone—systemic scleroderma	4.02e-05	0.000339	CcSEcCtD
Decitabine—Skin disorder—Methotrexate—systemic scleroderma	3.99e-05	0.000336	CcSEcCtD
Decitabine—Anorexia—Methotrexate—systemic scleroderma	3.92e-05	0.00033	CcSEcCtD
Decitabine—Urticaria—Prednisone—systemic scleroderma	3.91e-05	0.000329	CcSEcCtD
Decitabine—Abdominal pain—Prednisone—systemic scleroderma	3.89e-05	0.000328	CcSEcCtD
Decitabine—Body temperature increased—Prednisone—systemic scleroderma	3.89e-05	0.000328	CcSEcCtD
Decitabine—Hypotension—Methotrexate—systemic scleroderma	3.84e-05	0.000324	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.74e-05	0.000316	CcSEcCtD
Decitabine—Insomnia—Methotrexate—systemic scleroderma	3.72e-05	0.000313	CcSEcCtD
Decitabine—Dyspnoea—Methotrexate—systemic scleroderma	3.66e-05	0.000309	CcSEcCtD
Decitabine—Hypersensitivity—Prednisone—systemic scleroderma	3.62e-05	0.000305	CcSEcCtD
Decitabine—Dyspepsia—Methotrexate—systemic scleroderma	3.62e-05	0.000305	CcSEcCtD
Decitabine—Decreased appetite—Methotrexate—systemic scleroderma	3.57e-05	0.000301	CcSEcCtD
Decitabine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.55e-05	0.000299	CcSEcCtD
Decitabine—Fatigue—Methotrexate—systemic scleroderma	3.54e-05	0.000299	CcSEcCtD
Decitabine—Asthenia—Prednisone—systemic scleroderma	3.53e-05	0.000297	CcSEcCtD
Decitabine—Pain—Methotrexate—systemic scleroderma	3.51e-05	0.000296	CcSEcCtD
Decitabine—Pruritus—Prednisone—systemic scleroderma	3.48e-05	0.000293	CcSEcCtD
Decitabine—Feeling abnormal—Methotrexate—systemic scleroderma	3.39e-05	0.000285	CcSEcCtD
Decitabine—Diarrhoea—Prednisone—systemic scleroderma	3.36e-05	0.000284	CcSEcCtD
Decitabine—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.36e-05	0.000283	CcSEcCtD
Decitabine—Urticaria—Methotrexate—systemic scleroderma	3.27e-05	0.000275	CcSEcCtD
Decitabine—Dizziness—Prednisone—systemic scleroderma	3.25e-05	0.000274	CcSEcCtD
Decitabine—Abdominal pain—Methotrexate—systemic scleroderma	3.25e-05	0.000274	CcSEcCtD
Decitabine—Body temperature increased—Methotrexate—systemic scleroderma	3.25e-05	0.000274	CcSEcCtD
Decitabine—Vomiting—Prednisone—systemic scleroderma	3.13e-05	0.000263	CcSEcCtD
Decitabine—Rash—Prednisone—systemic scleroderma	3.1e-05	0.000261	CcSEcCtD
Decitabine—Dermatitis—Prednisone—systemic scleroderma	3.1e-05	0.000261	CcSEcCtD
Decitabine—Headache—Prednisone—systemic scleroderma	3.08e-05	0.00026	CcSEcCtD
Decitabine—Hypersensitivity—Methotrexate—systemic scleroderma	3.03e-05	0.000255	CcSEcCtD
Decitabine—Asthenia—Methotrexate—systemic scleroderma	2.95e-05	0.000248	CcSEcCtD
Decitabine—Nausea—Prednisone—systemic scleroderma	2.92e-05	0.000246	CcSEcCtD
Decitabine—Pruritus—Methotrexate—systemic scleroderma	2.91e-05	0.000245	CcSEcCtD
Decitabine—Diarrhoea—Methotrexate—systemic scleroderma	2.81e-05	0.000237	CcSEcCtD
Decitabine—Dizziness—Methotrexate—systemic scleroderma	2.72e-05	0.000229	CcSEcCtD
Decitabine—Vomiting—Methotrexate—systemic scleroderma	2.61e-05	0.00022	CcSEcCtD
Decitabine—Rash—Methotrexate—systemic scleroderma	2.59e-05	0.000218	CcSEcCtD
Decitabine—Dermatitis—Methotrexate—systemic scleroderma	2.59e-05	0.000218	CcSEcCtD
Decitabine—Headache—Methotrexate—systemic scleroderma	2.57e-05	0.000217	CcSEcCtD
Decitabine—Nausea—Methotrexate—systemic scleroderma	2.44e-05	0.000206	CcSEcCtD
